Solid execution across corporate, clinical and commercial initiatives Several key milestones advance 5x30 path to growth Conference call today at 4:30 p.m. ET BRISBANE, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today reported financial results for the second... Read More